• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共抑制因子受体相互作用蛋白140中四个自主抑制结构域的特征分析

Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140.

作者信息

Christian Mark, Tullet Jennifer M A, Parker Malcolm G

机构信息

Institute of Reproductive and Developmental Biology, Faculty of Medicine, Imperial College London, London W12 ONN, United Kingdom.

出版信息

J Biol Chem. 2004 Apr 9;279(15):15645-51. doi: 10.1074/jbc.M313906200. Epub 2004 Jan 21.

DOI:10.1074/jbc.M313906200
PMID:14736873
Abstract

Receptor interacting protein (RIP) 140 is a corepressor that can be recruited to nuclear receptors by means of LXXLL motifs. We have characterized four distinct autonomous repression domains in RIP140, termed RD1-4, that are highly conserved in mammals and birds. RD1 at the N terminus represses transcription in the presence of trichostatin A, suggesting that it functions by a histone deacetylase (HDAC)-independent mechanism. The repressive activity of RD2 is dependent upon carboxyl-terminal binding protein recruitment to two specific binding sites. Use of specific inhibitors indicates that RD2, RD3, and RD4 are capable of functioning by HDAC-dependent and HDAC-independent mechanisms, depending upon cell type.

摘要

受体相互作用蛋白(RIP)140是一种共抑制因子,可通过LXXLL基序被招募至核受体。我们已鉴定出RIP140中四个不同的自主抑制结构域,称为RD1 - 4,它们在哺乳动物和鸟类中高度保守。N端的RD1在曲古抑菌素A存在的情况下抑制转录,这表明它通过一种不依赖组蛋白脱乙酰基酶(HDAC)的机制发挥作用。RD2的抑制活性取决于羧基末端结合蛋白被招募至两个特定的结合位点。使用特异性抑制剂表明,RD2、RD3和RD4能够根据细胞类型,通过依赖HDAC和不依赖HDAC的机制发挥作用。

相似文献

1
Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140.共抑制因子受体相互作用蛋白140中四个自主抑制结构域的特征分析
J Biol Chem. 2004 Apr 9;279(15):15645-51. doi: 10.1074/jbc.M313906200. Epub 2004 Jan 21.
2
Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140.核内亚定位的调控与RIP140介导的核受体共抑制机制相关。
Mol Cell Biol. 2003 Jun;23(12):4187-98. doi: 10.1128/MCB.23.12.4187-4198.2003.
3
SUMOylation modulates the transcription repressor function of RIP140.小泛素样修饰(SUMOylation)调节RIP140的转录抑制功能。
J Biol Chem. 2008 Apr 25;283(17):11586-95. doi: 10.1074/jbc.M709359200. Epub 2008 Jan 22.
4
Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing.受体相互作用蛋白140直接募集组蛋白脱乙酰酶以实现基因沉默。
J Biol Chem. 2000 Dec 29;275(52):40782-7. doi: 10.1074/jbc.M004821200.
5
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms.配体依赖性核受体共抑制因子LCoR通过组蛋白去乙酰化酶依赖性和非依赖性机制发挥作用。
Mol Cell. 2003 Jan;11(1):139-50. doi: 10.1016/s1097-2765(03)00014-5.
6
Regulation of co-repressive activity of and HDAC recruitment to RIP140 by site-specific phosphorylation.通过位点特异性磷酸化对RIP140的共抑制活性及HDAC募集的调控。
Mol Cell Proteomics. 2005 Nov;4(11):1776-84. doi: 10.1074/mcp.M500236-MCP200. Epub 2005 Aug 10.
7
Characterization of receptor-interacting protein RIP140 in the regulation of SF-1 responsive target genes.受体相互作用蛋白RIP140在类固醇生成因子-1反应性靶基因调控中的特性分析
Mol Cell Endocrinol. 2003 May 30;203(1-2):91-103. doi: 10.1016/s0303-7207(03)00097-2.
8
Ligand-dependent formation of retinoid receptors, receptor-interacting protein 140 (RIP140), and histone deacetylase complex is mediated by a novel receptor-interacting motif of RIP140.类视黄醇受体、受体相互作用蛋白140(RIP140)和组蛋白脱乙酰酶复合物的配体依赖性形成是由RIP140的一个新的受体相互作用基序介导的。
J Biol Chem. 2001 May 11;276(19):16107-12. doi: 10.1074/jbc.M010185200. Epub 2001 Mar 5.
9
A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.雌激素受体(ER)与核受体辅阻遏物(NCoR)的融合蛋白可强烈抑制乳腺癌细胞中雌激素依赖性反应。
Mol Endocrinol. 1999 Dec;13(12):2122-36. doi: 10.1210/mend.13.12.0394.
10
The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.核受体共抑制因子(N-CoR)利用抑制结构域I和III与ETO相互作用并进行共抑制。
J Biol Chem. 2004 Nov 19;279(47):49281-8. doi: 10.1074/jbc.M407239200. Epub 2004 Sep 17.

引用本文的文献

1
Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.NRIP3 的甲基化是结PI3K 和 ATR/ATM 抑制剂在结直肠癌中的合成致死标志物。
Clin Transl Gastroenterol. 2024 Mar 1;15(3):e00682. doi: 10.14309/ctg.0000000000000682.
2
A truncating NRIP1 variant in an Arabic family with congenital anomalies of the kidneys and urinary tract.一个阿拉伯家族中与肾脏和泌尿道先天异常相关的 NRIP1 截断变异。
Am J Med Genet A. 2022 Jan;188(1):310-313. doi: 10.1002/ajmg.a.62502. Epub 2021 Sep 15.
3
Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis.
唐氏综合征个体骨密度的变化:系统评价和荟萃分析。
Osteoporos Int. 2022 Jan;33(1):27-37. doi: 10.1007/s00198-021-06070-7. Epub 2021 Aug 12.
4
RIP140 Represses Intestinal Paneth Cell Differentiation and Interplays with SOX9 Signaling in Colorectal Cancer.RIP140抑制肠道潘氏细胞分化并在结直肠癌中与SOX9信号相互作用。
Cancers (Basel). 2021 Jun 26;13(13):3192. doi: 10.3390/cancers13133192.
5
Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation.调控 LCoR 和 RIP140 表达在宫颈上皮内瘤变中的作用及其与 CIN 进展和去分化的相关性。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1847-1855. doi: 10.1007/s00432-020-03178-x. Epub 2020 Mar 10.
6
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.RIP140和LCoR作为宫颈癌预后不良独立标志物的研究
Oncotarget. 2017 Oct 31;8(62):105356-105371. doi: 10.18632/oncotarget.22187. eCollection 2017 Dec 1.
7
Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia.RIP140/NRIP1在慢性淋巴细胞白血病中的表达及作用
J Hematol Oncol. 2015 Mar 4;8:20. doi: 10.1186/s13045-015-0116-6.
8
RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis.RIP140 增加 APC 的表达,控制肠道稳态和肿瘤发生。
J Clin Invest. 2014 May;124(5):1899-913. doi: 10.1172/JCI65178. Epub 2014 Mar 25.
9
Nuclear hormone receptor co-repressors: structure and function.核激素受体共抑制因子:结构与功能。
Mol Cell Endocrinol. 2012 Jan 30;348(2):440-9. doi: 10.1016/j.mce.2011.08.033. Epub 2011 Sep 8.
10
Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?调控乳腺癌中的蛋白质乙酰化:与激素疗法联合的一种有前景的方法?
J Biomed Biotechnol. 2011;2011:856985. doi: 10.1155/2011/856985. Epub 2010 Dec 6.